Global Ioversol Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 157054
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Chemicals and Materials

Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.

Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.

Scope of the Report:

This report focuses on the Ioversol in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Ioversol is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Liebel-Flarsheim Company LLC

Guerbet

Jiangsu Hengrui Medicine Co

Mallinckrodt Pharmaceuticals

Ultraject

China Resources Pharmaceutical (Shanghai) Co

HB Ocean

Novalek Pharmaceuticals Pvt. Ltd

Stellence Pharmscience Pvt. Ltd

A.S. Joshi & Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ioversol 34% Injectable Solution (Optiray 160)

Ioversol 51% Injectable Solution (Optiray 240)

Ioversol 64% Injectable Solution (Optiray 300)

Ioversol 68% Injectable Solution (Optiray 320)

Ioversol 74% Injectable Solution (Optiray 350)

Market Segment by Applications, can be divided into

X-ray

CT Scan

Brain Disorders

Blood Vessel Disorders

Heart Disorders

Others

There are 15 Chapters to deeply display the global Ioversol market.

Chapter 1, to describe Ioversol Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ioversol, with sales, revenue, and price of Ioversol, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ioversol, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ioversol market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ioversol sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Ioversol Introduction

1.2 Market Analysis by Type

1.2.1 Ioversol 34% Injectable Solution (Optiray 160)

1.2.2 Ioversol 51% Injectable Solution (Optiray 240)

1.2.3 Ioversol 64% Injectable Solution (Optiray 300)

1.2.4 Ioversol 68% Injectable Solution (Optiray 320)

1.2.5 Ioversol 74% Injectable Solution (Optiray 350)

1.3 Market Analysis by Applications

1.3.1 X-ray

1.3.2 CT Scan

1.3.3 Brain Disorders

1.3.4 Blood Vessel Disorders

1.3.5 Heart Disorders

1.3.6 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Liebel-Flarsheim Company LLC

2.1.1 Business Overview

2.1.2 Ioversol Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Liebel-Flarsheim Company LLC Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Guerbet

2.2.1 Business Overview

2.2.2 Ioversol Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Guerbet Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Jiangsu Hengrui Medicine Co

2.3.1 Business Overview

2.3.2 Ioversol Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Jiangsu Hengrui Medicine Co Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Mallinckrodt Pharmaceuticals

2.4.1 Business Overview

2.4.2 Ioversol Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Mallinckrodt Pharmaceuticals Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Ultraject

2.5.1 Business Overview

2.5.2 Ioversol Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Ultraject Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 China Resources Pharmaceutical (Shanghai) Co

2.6.1 Business Overview

2.6.2 Ioversol Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 China Resources Pharmaceutical (Shanghai) Co Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 HB Ocean

2.7.1 Business Overview

2.7.2 Ioversol Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 HB Ocean Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Novalek Pharmaceuticals Pvt. Ltd

2.8.1 Business Overview

2.8.2 Ioversol Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novalek Pharmaceuticals Pvt. Ltd Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Stellence Pharmscience Pvt. Ltd

2.9.1 Business Overview

2.9.2 Ioversol Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Stellence Pharmscience Pvt. Ltd Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 A.S. Joshi & Company

2.10.1 Business Overview

2.10.2 Ioversol Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 A.S. Joshi & Company Ioversol Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ioversol Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Ioversol Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Ioversol Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Ioversol Manufacturer Market Share in 2017

3.3.2 Top 6 Ioversol Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Ioversol Market Analysis by Regions

4.1 Global Ioversol Sales, Revenue and Market Share by Regions

4.1.1 Global Ioversol Sales and Market Share by Regions (2013-2018)

4.1.2 Global Ioversol Revenue and Market Share by Regions (2013-2018)

4.2 North America Ioversol Sales and Growth Rate (2013-2018)

4.3 Europe Ioversol Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Ioversol Sales and Growth Rate (2013-2018)

4.5 South America Ioversol Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Ioversol Sales and Growth Rate (2013-2018)

5 North America Ioversol by Countries

5.1 North America Ioversol Sales, Revenue and Market Share by Countries

5.1.1 North America Ioversol Sales and Market Share by Countries (2013-2018)

5.1.2 North America Ioversol Revenue and Market Share by Countries (2013-2018)

5.2 United States Ioversol Sales and Growth Rate (2013-2018)

5.3 Canada Ioversol Sales and Growth Rate (2013-2018)

5.4 Mexico Ioversol Sales and Growth Rate (2013-2018)

6 Europe Ioversol by Countries

6.1 Europe Ioversol Sales, Revenue and Market Share by Countries

6.1.1 Europe Ioversol Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Ioversol Revenue and Market Share by Countries (2013-2018)

6.2 Germany Ioversol Sales and Growth Rate (2013-2018)

6.3 UK Ioversol Sales and Growth Rate (2013-2018)

6.4 France Ioversol Sales and Growth Rate (2013-2018)

6.5 Russia Ioversol Sales and Growth Rate (2013-2018)

6.6 Italy Ioversol Sales and Growth Rate (2013-2018)

7 Asia-Pacific Ioversol by Countries

7.1 Asia-Pacific Ioversol Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Ioversol Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Ioversol Revenue and Market Share by Countries (2013-2018)

7.2 China Ioversol Sales and Growth Rate (2013-2018)

7.3 Japan Ioversol Sales and Growth Rate (2013-2018)

7.4 Korea Ioversol Sales and Growth Rate (2013-2018)

7.5 India Ioversol Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Ioversol Sales and Growth Rate (2013-2018)

8 South America Ioversol by Countries

8.1 South America Ioversol Sales, Revenue and Market Share by Countries

8.1.1 South America Ioversol Sales and Market Share by Countries (2013-2018)

8.1.2 South America Ioversol Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Ioversol Sales and Growth Rate (2013-2018)

8.3 Argentina Ioversol Sales and Growth Rate (2013-2018)

8.4 Colombia Ioversol Sales and Growth Rate (2013-2018)

9 Middle East and Africa Ioversol by Countries

9.1 Middle East and Africa Ioversol Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Ioversol Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Ioversol Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Ioversol Sales and Growth Rate (2013-2018)

9.3 UAE Ioversol Sales and Growth Rate (2013-2018)

9.4 Egypt Ioversol Sales and Growth Rate (2013-2018)

9.5 Nigeria Ioversol Sales and Growth Rate (2013-2018)

9.6 South Africa Ioversol Sales and Growth Rate (2013-2018)

10 Global Ioversol Market Segment by Type

10.1 Global Ioversol Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Ioversol Sales and Market Share by Type (2013-2018)

10.1.2 Global Ioversol Revenue and Market Share by Type (2013-2018)

10.2 Ioversol 34% Injectable Solution (Optiray 160) Sales Growth and Price

10.2.1 Global Ioversol 34% Injectable Solution (Optiray 160) Sales Growth (2013-2018)

10.2.2 Global Ioversol 34% Injectable Solution (Optiray 160) Price (2013-2018)

10.3 Ioversol 51% Injectable Solution (Optiray 240) Sales Growth and Price

10.3.1 Global Ioversol 51% Injectable Solution (Optiray 240) Sales Growth (2013-2018)

10.3.2 Global Ioversol 51% Injectable Solution (Optiray 240) Price (2013-2018)

10.4 Ioversol 64% Injectable Solution (Optiray 300) Sales Growth and Price

10.4.1 Global Ioversol 64% Injectable Solution (Optiray 300) Sales Growth (2013-2018)

10.4.2 Global Ioversol 64% Injectable Solution (Optiray 300) Price (2013-2018)

10.5 Ioversol 68% Injectable Solution (Optiray 320) Sales Growth and Price

10.5.1 Global Ioversol 68% Injectable Solution (Optiray 320) Sales Growth (2013-2018)

10.5.2 Global Ioversol 68% Injectable Solution (Optiray 320) Price (2013-2018)

10.6 Ioversol 74% Injectable Solution (Optiray 350) Sales Growth and Price

10.6.1 Global Ioversol 74% Injectable Solution (Optiray 350) Sales Growth (2013-2018)

10.6.2 Global Ioversol 74% Injectable Solution (Optiray 350) Price (2013-2018)

11 Global Ioversol Market Segment by Application

11.1 Global Ioversol Sales Market Share by Application (2013-2018)

11.2 X-ray Sales Growth (2013-2018)

11.3 CT Scan Sales Growth (2013-2018)

11.4 Brain Disorders Sales Growth (2013-2018)

11.5 Blood Vessel Disorders Sales Growth (2013-2018)

11.6 Heart Disorders Sales Growth (2013-2018)

11.7 Others Sales Growth (2013-2018)

12 Ioversol Market Forecast (2018-2023)

12.1 Global Ioversol Sales, Revenue and Growth Rate (2018-2023)

12.2 Ioversol Market Forecast by Regions (2018-2023)

12.2.1 North America Ioversol Market Forecast (2018-2023)

12.2.2 Europe Ioversol Market Forecast (2018-2023)

12.2.3 Asia-Pacific Ioversol Market Forecast (2018-2023)

12.2.4 South America Ioversol Market Forecast (2018-2023)

12.2.5 Middle East and Africa Ioversol Market Forecast (2018-2023)

12.3 Ioversol Market Forecast by Type (2018-2023)

12.3.1 Global Ioversol Sales Forecast by Type (2018-2023)

12.3.2 Global Ioversol Market Share Forecast by Type (2018-2023)

12.4 Ioversol Market Forecast by Application (2018-2023)

12.4.1 Global Ioversol Sales Forecast by Application (2018-2023)

12.4.2 Global Ioversol Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Ioversol Picture

Table Product Specifications of Ioversol

Figure Global Sales Market Share of Ioversol by Types in 2017

Table Ioversol Types for Major M

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery